Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up

International Journal of Obesity volume 28, pages 1600–1606 (2004)Cite this article

Abstract

BACKGROUND: Obese patients are often affected by hypertension, dyslipidaemia, impaired glucose metabolism, and suffer from cardiovascular disease (CVD), related to the characteristic metabolic alterations.

AIM OF THE STUDY: To evaluate reduction of risk factors for CVDs in morbid-obese patients (body mass index (BMI)>40kg/m2) after weight loss upon bariatric surgery intervention of biliary-intestinal bypass.

SUBJECTS: 45 (17 men, 28 women) morbid-obese patients (age: 19–49 y, BMI>40 kg/m2). All patients were selected on the basis of medical history, physical and biochemical evaluation and of psychiatric tests, which were performed on all individuals admitted to our Day Hospital to verify the safety of surgical intervention.

MEASUREMENTS: Body weight, body composition (by dual X-ray absorptiometry, DXA), blood pressure, lipid profile, fibrinogen and glucose metabolism were monitored at baseline and 1, 3, 6, 9, 12, 24 and 36 months after surgery.

RESULTS: A significant and persistent weight loss was present in all patients at the end of the 3 y follow-up period (P<0.001), with a progressive reduction of total and trunk fat mass as evaluated by means of DXA. Additionally, a parallel significant reduction in systolic (P<0.001) and diastolic (P<0.001) blood pressure was observed. Total and LDL cholesterol were significantly reduced (P<0.001), while HDL showed no modifications; triglycerides declined progressively during the 3 y follow-up (P<0.001). Fibrinogen decreased from 364.5±82.4 to 266.4±45.7 mg/dl at the end of the period (P<0.001). Fasting glucose levels and glucose levels 120 min after an oral glucose tolerance test were reduced from 95.1±20.3 to 78.6±9.1 mg/dl (P<0.001) and from 116.9±34.7 to 77.6±15.5 mg/dl (P<0.001), respectively, at baseline and at the end of the study. Moreover, fasting insulin decreased from 30.0±20.4 to 8.6±2.9 μUI/ml (P<0.001) after 3 y, while insulin levels after (120 min) oral glucose load decreased from 105.5±61.5 to 12.0±6.0 μUI/ml (P<0.001).

CONCLUSION: Our results show that biliary-intestinal bypass may represent a valid and alternative therapeutic approach in patients with morbid obesity since it induces a significant and stable reduction of body weight and obesity-related risk factors for CVD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Rossner S . Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 2002; 26: S2–S4.

    Article  Google Scholar 

  2. Hu FB . Overweight and obesity in women: health risks and consequences. J Womens Health 2003; 12: 163–172.

    Article  Google Scholar 

  3. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series, Vol 894. WHO: Geneva; 2000. pp 1–253.

  4. Lebovitz HE . The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003; 134: 18–27.

    CAS  Google Scholar 

  5. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S . Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420–425.

    Article  CAS  Google Scholar 

  6. Reaven GM . Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  Google Scholar 

  7. Zimmet PZ . Kelly West Lecture 1991: challenges in diabetes epidemiology: from West to the rest. Diabetes Care 1992; 15: 232–252.

    Article  CAS  Google Scholar 

  8. Kaplan NM . The deadly quartet: upper body adiposity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch Intern Med 1989; 149: 1514–1520.

    Article  CAS  Google Scholar 

  9. Kolanowski J . Pathophysiology and treatment of the obesity-related arterial hypertension. Acta Clin Belg 1992; 47 (Suppl 14): 18–25.

    Article  Google Scholar 

  10. Avellone G, Di Garbo V, Cordova R, Ranelli G, De Simone R, Bompiani G . Coagulation, fibrinolysis, and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994; 75: 223–231.

    Article  CAS  Google Scholar 

  11. Haheim LL, Holme I, Hjermann I, Leven P . Risk factors of stroke incidence and mortality. A 12-year follow up of the Oslo Study. Stroke 1993; 24: 1484–1489.

    Article  CAS  Google Scholar 

  12. Barrett-Connor E . Obesity, atherosclerosis and coronary artery disease. Ann Intern Med 1985; 103: 1010–1019.

    Article  CAS  Google Scholar 

  13. Manson JE, Stampfer MJ, Hennekens CH, Willett WC . Body weight and longevity. JAMA 1987; 257: 353–358.

    Article  CAS  Google Scholar 

  14. Bray GA, Gray DS . Obesity: Part II. Treatment. West J Med 1988; 149: 555–571.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Garrow JS . Morbid obesity: medical or surgical treatment? The case for medical treatment. Int J Obes 1987; 11: 1–4.

    PubMed  Google Scholar 

  16. Schurgin S, Siegel RD . Pharmacotherapy of obesity: an update. Nutr Clin Care 2003; 6: 27–37.

    PubMed  Google Scholar 

  17. Weigle DS . Pharmacological therapy of obesity: past, present, and future. J Clin Endocrinol Metab 2003; 88: 2462–2469.

    Article  CAS  Google Scholar 

  18. LIGIO ‘99 II.D.6.6. p 15.

  19. Eriksson F . Biliointestinal by-pass. Int J Obes 1981; 5: 437–447.

    CAS  PubMed  Google Scholar 

  20. Bomann L, Domellof L . Biliary-intestinal by-pass in the treatment of obesity: long term follow up. Eur J Surg 1998; 164: 943–949.

    Article  Google Scholar 

  21. Doldi SB . Bilio-intestinal by-pass: another surgical option. Obes Surg 1998; 8: 566–569.

    Article  CAS  Google Scholar 

  22. Badiali M, D'Agostini A, Filippis AM, Corradini SG, Grossi A, Eramo A, Spera G, Lubrano C, Massa R, Scopinaro F . Patency of anastomoses after bilio-intestinal bypass: radioisotope demonstration. Obes Surg 2001; 11: 615–618.

    Article  CAS  Google Scholar 

  23. Galati G, Izzo L, Binda B, De Cesare A, Fiori E, Bononi M, Masoni L, Badiali M . Biliary-intestinal bypass in the treatment of severe obesity: personal experience with 23 patients. Minerva Chir 2001; 56: 345–349.

    CAS  PubMed  Google Scholar 

  24. Cugini P, Spera G, De Rosa R, Falcone S, Pandolfi C, Badiali M . The orexigram in patients affected by morbid obesity: a preliminary report on daily high sensation before bariatric surgery. Eat Weight Disord 2003; 8: 194–200.

    Article  CAS  Google Scholar 

  25. Pietrobelli A, Formica C, Wang Z, Heymsfield SB . Dual-energy X-ray absorptiometry body composition model: review of concepts. Am J Physiol 1996; 271 (Endocrinology Metabolism 34): E941–E951.

    CAS  Google Scholar 

  26. Alberti KGMM, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 1998; 15: 539–553.

    Article  CAS  Google Scholar 

  27. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 (Suppl 1): S4–S19.

  28. Poulter N . Global risk of cardiovascular disease. Heart 2003; 89 (Suppl 2): ii2–ii5 discussion ii5–ii7.

    PubMed  PubMed Central  Google Scholar 

  29. Della Guardia P, Grossi A, Elisei W, Eramo A, de Santis AD, Attili AF, Genco A, Basso N, Ginanni Corradini SG . Plasma lipoproteins affect rate of cholesterol absorbed from bile by gallbladder: preliminary data. Ital J Gastroenterol Hepatol 1999; 31: 587–592.

    CAS  PubMed  Google Scholar 

  30. Ginanni Corradini S, Eramo AR, Grossi A, D'Agostini A, Scopinaro F, Lubrano C, Spera G . The biliary-intestinal by-pass lowers total cholesterol and LDL-cholesterol plasma levels by reducing biliary cholesterol absorption. Hepato-Gastroenterology 1999; 46 (Suppl III): IV10.

    Google Scholar 

  31. Ginanni Corradini S, Eramo AR, Grossi A, D'Agostini A, Scopinaro F, Lubrano C, Spera G . Reducing the absorption of biliary cholesterol with a biliary-intestinal by-pass lowers the total and LDL cholesterol plasma levels. Hepato-Gastroenterology 1999; 30: 523A.

    Google Scholar 

  32. Busetto L, Pisent C, Rinaldi D, Longhin PL, Segato G, De Marchi F, Foletto M, Favretti F, Lise M, Enzi G . Variations in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss. Obes Surg 2000; 10: 569–577.

    Article  CAS  Google Scholar 

  33. Brolin RE, Bradley LJ, Wilson AC, Cody RP . Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 2000; 4: 464–469.

    Article  CAS  Google Scholar 

  34. Avellone G, Di Garbo V, Cordova R, Ranelli G, De Simone R, Bompiani G . Coagulation, fibrinolysis, and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994; 75: 223–231.

    Article  CAS  Google Scholar 

  35. Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A . Weight change and blood coagulability and fibrinolysis in healthy obese women. Int J Obes Relat Metab Disord 2001; 25: 212–218.

    Article  CAS  Google Scholar 

  36. Bonora E, Micciolo R, Ghiatas AA, Lancaster JL, Alyassin A, Muggeo M, De Fronzo RA . It is possible to derive a reliable estimate of human visceral and subcutaneous abdominal tissue from simple anthropometric measurements? Metabolism 1995; 44: 1617–1625.

    Article  CAS  Google Scholar 

  37. Lancaster JL, Ghiatas AA, Alyassin A, Kilcoyne RF, Bonora E, De Fronzo RA . Measurement of abdominal fat with T1-weighted MR image. J Magn Reson Imag 1991; 1: 363–369.

    Article  CAS  Google Scholar 

  38. Staessen J, Fagard R, Amery A . The relation between body weight and blood pressure. Hum Hypertens 1988; 2: 207–217.

    CAS  Google Scholar 

  39. Selby JV, Friedman GD, Quesenberry Jr CP . Precursor of essential hypertension. The role of body fat distribution pattern. Am J Epidemiol 1989; 129: 43–53.

    Article  CAS  Google Scholar 

  40. Letiexhe MR, Scheen AJ, Gerard PL, Desaive C, Lefebvre PJ . Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab 1995; 80: 364–369.

    CAS  PubMed  Google Scholar 

  41. Scopinaro N, Marinari G, Adami G, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A . The effect of bilio-pancreatic diversion on glucose and cholesterol metabolism. Obes Surg 1998; 8: 151.

    Google Scholar 

  42. Pories W, Hickey MS, MacDonald K . Prevention and control of type 2 diabetes mellitus with gastric by-pass surgery. Int J Obes Relat Metab Disord 1998; 22 (Suppl S85): 35.

    Google Scholar 

  43. De Simone G, Devereux RB, Palmieri V, Roman MJ, Celentano A, Welty TK, Fabsitz RR, Contaldo F, Howard BV . Relation of insulin resistance to markers of preclinical cardiovascular disease: the Strong Heart Study. Nutr Metab Cardiovasc Dis 2003; 13: 140–147.

    Article  CAS  Google Scholar 

  44. Sowers JR . Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8A): 37S–41S.

    Article  CAS  Google Scholar 

  45. Brochier ML, Arwidson P . Coronary heart disease risk factors in women. Eur Heart J 1998; 19 (Suppl A): A45–A52.

    PubMed  Google Scholar 

  46. Anderson JW, Hamilton CC, Brinkman-Kaplan V . Benefits and risks of an intensive very-low-calorie-diet program for severe obesity. Am J Gastroenterol 1992; 87: 6–15.

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. C Lubrano and A Cornoldi: These authors contributed equally to this work.

Authors and Affiliations

  1. Dipartimenti di Fisiopatologia Medica, Università degli Studi di Roma ‘La Sapienza’, Policlinico Umberto I, Roma, Italia

    C Lubrano, A Cornoldi, M Pili, S Falcone, F Brandetti, E Fabbrini, S Migliaccio, N Falsetto & G Spera

  2. Medicina Clinica, Università degli Studi di Roma ‘La Sapienza’, Policlinico Umberto I, Roma, Italia

    S Ginanni-Corradini & A Eramo

  3. Scienze Radiologiche, Università degli Studi di Roma ‘La Sapienza’, Policlinico Umberto I, Roma, Italia

    M Marini & G Prossomariti

  4. Scienze Neurologiche e Psichiatriche, Università degli Studi di Roma ‘La Sapienza’, Policlinico Umberto I, Roma, Italia

    V Giancotti

  5. Scienze Chirurgiche, Università degli Studi di Roma ‘La Sapienza’, Policlinico Umberto I, Roma, Italia

    M Badiali

Authors
  1. C Lubrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Cornoldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Pili
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Falcone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Brandetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Fabbrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Ginanni-Corradini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Eramo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Marini
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S Migliaccio
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. V Giancotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M Badiali
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. N Falsetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. G Prossomariti
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. G Spera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Spera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lubrano, C., Cornoldi, A., Pili, M. et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up. Int J Obes 28, 1600–1606 (2004). https://doi.org/10.1038/sj.ijo.0802782

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802782

Keywords

This article is cited by

Search

Advanced search

Quick links